420 results on '"Suntharalingam, Mohan"'
Search Results
2. A phase II trial of reirradiation combined with pembrolizumab in patients with locoregional inoperable recurrence or second primary squamous cell carcinoma of the head and neck (HNSCC).
3. Risk groups of laryngeal cancer treated with chemoradiation according to nomogram scores – A pooled analysis of RTOG 0129 and 0522
4. Insurance Status is an Independent Predictor of Overall Survival in Patients With Stage III Non–small-cell Lung Cancer Treated With Curative Intent
5. Downstream Effect of a Proton Treatment Center on an Academic Medical Center
6. Lymph Node Size Predicts for Asymptomatic Brain Metastases in Patients With Non–small-cell Lung Cancer at Diagnosis
7. Implications of Pathologic Complete Response Beyond Mediastinal Nodal Clearance With High-Dose Neoadjuvant Chemoradiation Therapy in Locally Advanced, Non-Small Cell Lung Cancer
8. Multi-institutional analysis of radiation modality use and postoperative outcomes of neoadjuvant chemoradiation for esophageal cancer
9. Head and Neck Tumors: Viewpoint—Fractionated Radiation Therapy and Chemotherapy
10. Association of Radiotherapy Duration With Clinical Outcomes in Patients With Esophageal Cancer Treated in NRG Oncology Trials
11. Perspective on This Article from Racial Survival Disparity in Head and Neck Cancer Results from Low Prevalence of Human Papillomavirus Infection in Black Oropharyngeal Cancer Patients
12. Data from Racial Survival Disparity in Head and Neck Cancer Results from Low Prevalence of Human Papillomavirus Infection in Black Oropharyngeal Cancer Patients
13. Press Coverage from Racial Survival Disparity in Head and Neck Cancer Results from Low Prevalence of Human Papillomavirus Infection in Black Oropharyngeal Cancer Patients
14. Contributors
15. Early Tongue Cancer
16. Long-Term Results of Radiation Therapy Oncology Group 9903: A Randomized Phase 3 Trial to Assess the Effect of Erythropoietin on Local-Regional Control in Anemic Patients Treated With Radiation Therapy for Squamous Cell Carcinoma of the Head and Neck
17. Modeling Pathologic Response of Esophageal Cancer to Chemoradiation Therapy Using Spatial-Temporal 18F-FDG PET Features, Clinical Parameters, and Demographics
18. Head and Neck Malignancies: Chemotherapy and Radiation Perspective
19. Carcinoma of the Esophagus
20. Spatial-Temporal [18F]FDG-PET Features for Predicting Pathologic Response of Esophageal Cancer to Neoadjuvant Chemoradiation Therapy
21. Effect of the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation Therapy for Patients With Esophageal Cancer: The NRG Oncology RTOG 0436 Phase 3 Randomized Clinical Trial
22. Radiation Therapy Oncology Group Protocol 02-29: A Phase II Trial of Neoadjuvant Therapy With Concurrent Chemotherapy and Full-Dose Radiation Therapy Followed by Surgical Resection and Consolidative Therapy for Locally Advanced Non-small Cell Carcinoma of the Lung
23. Primary Gross Tumor Volume is an Important Prognostic Factor in Locally Advanced Esophageal Cancer Patients Treated with Trimodality Therapy
24. A phase I dose escalation trial of MAGE-A3- and HPV16-specific peptide immunomodulatory vaccines in patients with recurrent/metastatic (RM) squamous cell carcinoma of the head and neck (SCCHN)
25. Evaluation of the Role of Radiation Therapy in the Management of Malignant Thymoma
26. Phase II Study Evaluating the Addition of Cetuximab to the Concurrent Delivery of Weekly Carboplatin, Paclitaxel, and Daily Radiotherapy for Patients With Locally Advanced Squamous Cell Carcinomas of the Head and Neck
27. Primary Tumor Volume Is an Important Predictor of Clinical Outcomes Among Patients With Locally Advanced Squamous Cell Cancer of the Head and Neck Treated With Definitive Chemoradiotherapy
28. Impact of Neoadjuvant Radiation on Survival in Stage III Non–Small-Cell Lung Cancer
29. Palliative Radiation for Pulmonary Widespread Disease
30. Oropharyngeal cancer as a driver of racial outcome disparities in squamous cell carcinoma of the head and neck: 10-year experience at the University of Maryland Greenebaum Cancer Center
31. Eliminating Complex Treatment Setup for Intact Breast or Postmastectomy Treatment with Intensity Modulated Radiation Therapy
32. Monte Carlo dosimetry for intravascular brachytherapy
33. Phase I trial of carboplatin/paclitaxel/bortezomib and concurrent radiotherapy followed by surgical resection in Stage III non-small cell lung cancer
34. Pneumonectomy for Lung Cancer After Preoperative Concurrent Chemotherapy and High-Dose Radiation
35. Do Tumors in the Lung Deform During Normal Respiration? An Image Registration Investigation
36. Prevalence and correlates of symptoms and uncertainty in illness among head and neck cancer patients receiving definitive radiation with or without chemotherapy
37. An evaluation of planning techniques for stereotactic body radiation therapy in lung tumors
38. Phase I/II Trial of Hyperfractionated Radiation and Chemotherapy Followed by Surgery in Stage III Lung Cancer
39. Clinical utility of postchemoradiation endoscopic brush cytology and biopsy in predicting residual esophageal adenocarcinoma
40. The Use of Gated and 4D CT Imaging in Planning for Stereotactic Body Radiation Therapy
41. Two-year clinical follow-up of 90Sr/90Y beta-radiation versus placebo control for the treatment of in-stent restenosis
42. The management of the patient undergoing combined modality therapy for locally advanced non-small cell lung cancer
43. Single-fraction radiotherapy versus multifraction radiotherapy for palliation of painful vertebral bone metastases—Equivalent efficacy, less toxicity, more convenient:A subset analysis of Radiation Therapy Oncology Group trial 97-14
44. inducTION of mage-A3 and HPV-16 immunity by Trojan vaccines in patients with head and neck carcinoma
45. Promoter Methylation and Response to Chemotherapy and Radiation in Esophageal Cancer
46. Impact of early percutaneous endoscopic gastrostomy tube placement on nutritional status and hospitalization in patients with head and neck cancer receiving definitive chemoradiation therapy
47. Adjuvant Radiation Therapy for High-Grade and/or Locally Advanced Major Salivary Gland Tumors
48. Resection following concurrent chemotherapy and high-dose radiation for stage IIIA non–small cell lung cancer
49. PATTERNS OF FAILURE AMONG PATIENTS WITH SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK WHO OBTAIN A COMPLETE RESPONSE TO CHEMORADIOTHERAPY#
50. Race impacts outcome in stage III/IV squamous cell carcinomas of the head and neck after concurrent chemoradiation therapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.